Linked Data API

Show Search Form

Search Results

1337938
registered interest false more like this
date less than 2021-06-17more like thismore than 2021-06-17
answering body
Department for Business, Energy and Industrial Strategy more like this
answering dept id 201 more like this
answering dept short name Business, Energy and Industrial Strategy more like this
answering dept sort name Business, Energy and Industrial Strategy more like this
hansard heading Medicine: Research more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps he is taking to (a) modernise medical research and (b) replace animal testing with human-relevant techniques. more like this
tabling member constituency Coventry South more like this
tabling member printed
Zarah Sultana more like this
uin 17857 remove filter
answer
answer
is ministerial correction false more like this
date of answer less than 2021-06-24more like thismore than 2021-06-24
answer text <p>As part of a modern research system, we believe that animals should only be used where there is no practical alternative. The use of animals in research is carefully regulated and remains important in ensuring new medicines and treatments are safe.</p><p> </p><p>However, we are actively supporting and funding the development and dissemination of techniques that replace, reduce and refine the use of animals in research (the 3Rs).  This is achieved primarily through funding for the National Centre for the 3Rs which works nationally and internationally to drive the uptake of 3Rs technologies and ensure that advances in the 3Rs are reflected in policy, practice and regulations on animal research.  Since the NC3Rs was launched it has committed £100 million through its research, innovation, and early career awards to provide new 3Rs approaches for scientists in academia and industry to use. This includes almost £27 million in contracts through its CRACK IT Challenges innovation scheme to UK and EU-based institutions, mainly focusing on new approaches for the safety assessment of pharmaceuticals and chemicals that reduce the use of animals.</p><p> </p><p>UK Research and Innovation (UKRI) funds a portfolio of research projects involving humans, human materials, animal models, and non-animal technologies. At this time, no artificial model or simulation can replicate the complexity of disease processes in a living organism and as such, whole organism approaches continue to be important; animal models are used when experimentation in human volunteers is not possible for safety or ethical reasons. However, we do recognise the increasing value of <em>in vitro</em> and <em>in silico</em> models, including organs-on-chips and 3-dimensional mini-brains, which can greatly aid the development of new healthcare innovations and also reduce, refine or replace the use of animals in research.</p><p> </p>
answering member constituency Derby North more like this
answering member printed Amanda Solloway more like this
question first answered
less than 2021-06-24T12:10:25.15Zmore like thismore than 2021-06-24T12:10:25.15Z
answering member
4372
label Biography information for Amanda Solloway more like this
tabling member
4786
label Biography information for Zarah Sultana more like this